37

Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Embed Size (px)

Citation preview

Page 1: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease
Page 2: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

WILLIAMS 2001

Thyroid Disease in Pregnancy

Page 3: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

CONTENTSI. HyperthyroidismII. Subclinical thyotoxicosisIII. HypothyroidismIV. Subclinical hypothyroidismV. Nodular thyroid diseaseVI. Postpartum thyroiditis

Page 4: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

INTRODUCTIONSporadic nontoxic goiter = 5%

Hyperthyroidism = 1%Hypothyroidism = 1%Postpartum thyroiditis = 1%Relation of thyroid gland to pregnancy:

Alter thyroid function tests Drugs used pass to fetal thyroid Related abnormal conditions:

o GTD thyrotoxicosiso ATA ↑ % of abortiono Hyper/hypothyroidism adverse pregnancy outcome.

Page 5: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

PHYSIOLOGY The thyroid gland moderately enlarge during

pregnancy due to ↑ vascularity and hyperplasia. Histologically active gland. U/S ↑ volume.

Laboratory investigations: ↑ T3, T4

↑radioactive iodine uptake ↑TBG TRHundetected, fetal TRH detected >20 weeks TSH unchanged (cross react with FSH, LH, hCG)

Early in pregnancy T4 ↑, TSH ↓ ( within normal range).

Page 6: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

HYPERTHYROIDISM Thyrotoxicosis and pregnancy Treatment Pregnancy outcome Thyroid storm and heart failure Effects on the neonate Neonatal thyrotoxicosis after

thyroid ablation

Page 7: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

= %1 : 2000 of pregnanciesSymptoms in mild cases:

Tachycardia ↑ sleeping pulse rate Thyromegaly Exophthalmos No ↑ weight

Page 8: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Confirm diagnosis by: Free T4 ↑ TSH↓ Rarely T4 is normal, T3 is ↑

% =5 in old women In young women sometimes

excessive thyroxin treatment thyrotoxicosis.

Page 9: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

THYROTOXICOSIS AND PREGNANCY

= Graves disease = organ specific autoimmune disease TSAbs = TSH. Remission occur during pregnancy due to TSBAbs. Recurrence of thyrotoxicosis occur 4 months pp.Treatment:

Thioamides: - propylthiouracil - methimazole

Propylthiouracil: prevent T3 T4 less placental cross no aplasia cutis

Compared to methimazole. Both are safe .

Page 10: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Side effects:10% leukopenia do not stop ttt0.2% agranulocytosis stop treatment

Any sore throatstop treatment and do CBPDosage in nonpregnant:Propylthiouracil = 100 – 600 mg/dayMethimazole = 10 -- 40 mg/day

Page 11: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Dosage in pregnant: Propylthiouracil = 300 - 450 mg/day Methimazole = 10 - 40 mg/day

Median time for normalization = 7-8 weeks Study:

Pregnant women treated by 600 mg/day propylthiouracil 50 % remission

33 % require ↑ treatment at delivery 10 % used 150 mg/day

Carbimazole 25 % remission

Page 12: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Thyroidectomy:Indications:

Cannot adhere to oral ttt Toxicity from oral ttt

Dangers: ↑ vascularity give medical ttt before

surgery

2 % vocal cord palsy 3 % hypoparathyroidism

Page 13: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Pregnancy Outcome ↑ preeclampsia ↑ HFPerinatal mortality: 8 – 12 %

Thyroid storm: Rarely occur in untreated patients

due to a large functioning tumor .

Page 14: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Heart failure: More common than thyroid storm. Due to

myocardial effects of T4 = constant exercise

% in untreated cases = 8% % in treated cases = 3 %

Precipitated by: Preeclampsia Infection anemia

Page 15: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Management in ICU :1 - Propylthiouracil:

Initial dose = 1 gm Orally Maintenance dose = 200mg /6hours

2 - After 1 hour Iodide to prevent T3T4

Supersaturated SKI = 5 drops/8hours Lugol solution = 10 drops/8hours

Page 16: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

3 - If allergic to Iodine Lithium carbonate = 300 mg/day

Monitor S. lithium = 0.5 - 1.5mmol/L4 - Corticosteroides to further prevent T3T4

Dexamethasone = 2 mg/6 hours I.V 5 - β-blockers for symptoms

6 - Aggressive management of: HTN/infection/anemia

Page 17: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Effects on the neonate:May transient hyperthyroidism/hypothyroidismBoth fetal goiterThiourea drugs

Commonly not used during pregnancy although it extremely small risk (< 3%)

Case : Excessive propylthiouracilfetal hypothyroidism

at 28 weeks confirmed by CBS. Intera-amnionic injection of T4 at 35, 36, 37 weeks recovery.

Page 18: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Neonatal thyrotoxicosis after maternal thyroid ablation by surgery /radiation

Thyroid ablation in women with Graves disease does not remove maternal TSAbs in her blood which cross the placenta to the fetus and may fetal HF and death ( non-immune hydrops from fetal thyrotoxicosis ).

Fetal thyrotoxicosis can be diagnosed By ↑ FHS and CBS .

Page 19: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

SUBCLINICAL THYROTOXICOSIS

GTD

Page 20: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

=free T4 normal, TSH ↓ %4 50% due to excessive T4 ttt

50% variable course 40% no thyrotoxicosisLong -term effects:

Cardiac arrhythmia/hypertrophy Osteopenia

If persistent ↓TSH follow up and monitor periodically

Page 21: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

HYPOTHYROIDISM

Page 22: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

=↓free T4, ↑ TSHRarely become pregnant infertileTreatment:Thyroxine: 50 - 100 μg/dayMonitoring: by TSH/ 4 - 6 weeksAim = T4 ≤ normal ↑↓ by 25 - 50 μgDuring pregnancy monitor: TSH/trimesterStudy: T4 requirement during pregnancy do not ↑ in 80%

Page 23: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

SUBCLINICAL HYPOTHYROIDISM

Effects on the fetus and infant Radioiodine treatment Iodine deficiency Congenital hypothyroidism Preterm infants

Page 24: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

=normal free T4 + ↑ TSH =5 % in women from 18 - 45 years

10 - 20% of them overt hypothyroidism 1 - 4 years later

Risk factors: TSH > 10 mU/L antimicrosomal antibodies

%↑in type 1 DMPregnancy outcome ↑ PTL + HTN

Page 25: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

EFFECT ON THE FETUS AND INFANT:

In the past : no adverse effectsNow:T4 < 10th percentile impaired psychological developmentTSH >99.6th percentile↓school performance ↓ reading recognition

↓I.Q .Most cases are impending thyroid failure .

Page 26: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Radioiodine therapy: destruction of fetal thyroid

Exposed fetuses: Evaluate Give prophylactic thyroid hormone Consider abortion

Congenital anomalies: 2 studies no ↑ 1 study 1 : 73

No pregnancy for 1 year after treatment

Page 27: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Iodine Deficiency endemic cretinism in endemic areas

20 million people with preventable brain damageIodine unsupplementation:

↑TSH to 19 mIU/mL # 9 ↑Neurological abnormalities to 9% #

3%

Page 28: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Congenital hypothyroidism = 1 : 4000 – 7000 infants

Usually missed Due to:

75 % thyroid agenesis 10 % thyroid hormonoagenesis 10 % transient hypothyroidism

Neonatal screening is mandatoryEarly ttt normal neurological development

Page 29: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Preterm fetuses May develop transient

hypothyroidism .Treatment unnecessary.

Page 30: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

NODULAR THYROID DISEASE

Page 31: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

-Evaluation and management depend on GA. -Malignant nodules = 5 – 30 % mostly low

malignant tumors . -Radioiodine scanning is commonly not used

although it has minimal effect on the fetus.

-U/S can detect > 0.5 cm nodules . -FNA is an excellent method during pregnancy

-Study : malignancy by FNA = 40%

Page 32: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Indications of biopsy of nonfunctioning nodules

<20 weeks: Solid nodule > 2 cm Cystic nodule > 4 cm Growing Lymphadenopathy

Course: indolent surgery can be postponedPregnancy outcome = same as none pregnantThyroidectomy < 24 - 26 weeks no PTL

Page 33: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

POSTPARTUM THYROIDITIS

Page 34: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Propensity antedate pregnancyPrecipitated by:

- Viral infection - Others as Chernobyl disaster

Characterized by: - transient pp hypothyroidism - transient pp hyperthyroidism

%by carful evaluation = 7 – 10% Usually missed because symptoms are nonspecific as:

Depression Carelessness ↓ memory

Page 35: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Study : depression = 9 % at 6 months pp %in type I DM = 25%

Risk factors: Previous attach Personal history of autoimmune disease Family “”””””””””””””””””””””””””””””””””” ↓ iodineMany patients have thyroid antibodies before pregnancyPathophysiology:Viral infection immune activation autoantibodies disruption + lymphocytic thyroidites

Page 36: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Thyroid autoantibodies:1 - Microsomal autoantibodies:

% 7-10 early in pregnancy and pp

Study: = 20% < 13 weeks 17% spontaneous abortion

Characteristics : ↓ during pregnancy ↑ 4 - 6 months pp ↓ 10 - 12 months pp

2 - Peroxidase autoantibodies: % ↑of thyroid failure

Both identify women at high risk of thyroid failure

Page 37: Thyroid Disease in Pregnancy I. Hyperthyroidism II. Subclinical thyotoxicosis III. Hypothyroidism IV. Subclinical hypothyroidism V. Nodular thyroid disease

Clinical picture: Hyperthyroidism

Hypothyroidism %4% 2-5%

Occurrence pp 1 - 4 months 4 - 8 monthsSymptoms small painless goiter goiter, fatigue

fatigue, palpitation depression,↓concentration Cause disruption induced thyroid failure

hormone release Treatment β-blockers thyroxin 6-12 monthsFate 2/3 recovery 1/3 thyroid failure

1/3 hypothyroidism